Towa Pharmaceutical Co., Ltd. (TYO:4553)
Japan · Delayed Price · Currency is JPY 3,855.00
-55.00 (-1.41%)
Aug 4, 2026, 10:00 AM JST
Towa Pharmaceutical Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 273,710 | 273,710 | 259,594 | 227,934 | 208,859 | 165,615 |
Revenue Growth | 5.44% | 5.44% | 13.89% | 9.13% | 26.11% | 6.92% |
Gross Profit Gross Profit Growth | 99,104 | 99,104 | 94,729 | 81,383 | 72,714 | 70,186 |
Operating Income Operating Income Growth | 23,103 | 23,103 | 23,243 | 17,648 | 5,515 | 18,538 |
Net Income Net Income Growth | 5,250 | 5,250 | 18,986 | 16,173 | 2,201 | 15,914 |
Earnings Per Share EPS Growth | 106.65 | 106.65 | 385.70 | 328.58 | 44.72 | 316.19 |
EPS Growth | -72.35% | -72.35% | 17.38% | 634.82% | -85.86% | 16.28% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Unallocated Adjustment Amount Unallocated Adjustment Amount Growth | -895 | -895 | -374 | -105 | -166 | - |
Domestic Domestic Growth | 216,976 | 216,976 | 206,103 | 178,715 | 155,538 | 126,676 |
Overseas Overseas Growth | 57,630 | 57,630 | 53,865 | 49,324 | 53,487 | 38,938 |
Total Total Growth | 273,711 | 273,711 | 259,594 | 227,934 | 208,859 | 165,614 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 45,306 | 45,306 | 45,471 | 29,650 | 24,257 | 32,830 |
Total Debt Total Debt Growth | 228,952 | 228,952 | 236,341 | 206,171 | 173,065 | 144,128 |
Net Cash (Debt) Net Cash Growth | -183,646 | -183,646 | -190,870 | -176,521 | -148,808 | -111,298 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -3730.55 | -3730.55 | -3877.50 | -3586.33 | -3023.21 | -2211.60 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 30,429 | 30,429 | 23,401 | 8,212 | 2,544 | 22,129 |
Capital Expenditures CapEx Growth | -22,277 | -22,277 | -28,736 | -37,851 | -28,731 | -11,140 |
Free Cash Flow Free Cash Flow Growth | 8,152 | 8,152 | -5,335 | -29,639 | -26,187 | 10,989 |
Free Cash Flow Growth | - | - | - | - | - | 282.76% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 36.21% | 36.21% | 36.49% | 35.70% | 34.82% | 42.38% |
Operating Margin | 8.44% | 8.44% | 8.95% | 7.74% | 2.64% | 11.19% |
Pretax Margin | 4.81% | 4.81% | 10.14% | 10.73% | 2.20% | 13.43% |
Profit Margin | 1.92% | 1.92% | 7.31% | 7.09% | 1.05% | 9.61% |
FCF Margin | 2.98% | 2.98% | -2.05% | -13.00% | -12.54% | 6.64% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 85.000 | 80.000 | 70.000 | 60.000 | 60.000 | 57.000 |
Dividend Per Share Growth | 0% | 14.29% | 16.67% | 0% | 5.26% | 29.54% |
Dividend Yield | 2.12% | 2.00% | 2.67% | 2.17% | 3.39% | 2.29% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 36.66 | 37.55 | 6.95 | 8.84 | 42.38 | 8.53 |
Forward PE | 8.57 | 9.78 | 8.37 | 11.99 | 11.96 | 8.06 |
P/FCF Ratio | 23.61 | 24.19 | - | - | - | 12.35 |
PS Ratio | 0.70 | 0.72 | 0.51 | 0.63 | 0.45 | 0.82 |